Capstone Cash Flow Statement
NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Capstone free cash flow
In fiscal 2025, Capstone generated -$4.4 million of operating cash flow and spent $122,000 on capital expenditures. That left free cash flow of -$4.5 million, a free-cash-flow margin of -9.7% of revenue. Free cash flow was down 222.5% from the prior year's $3.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
Capstone cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 | FY 20152015-12-31 | FY 20142014-12-31 | FY 20132013-12-31 | FY 20122012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -21.23M | -2.56M | -3.82M | 380.00K | 1.75M | -1.61M | -2.77M | -4.17M | -4.11M | -4.05M |
| Net Income growth (YoY) | — | — | -1105.00% | -78.35% | — | — | — | — | — | — |
| Depreciation & Amortization | 391.00K | 310.00K | 461.00K | — | — | 179.00K | 157.00K | 160.00K | 173.00K | 29.00K |
| Stock-Based Compensation | 0 | 0 | — | 15.00K | 0 | 35.00K | 174.00K | 53.00K | 34.00K | 107.00K |
| Change in Working Capital | -986.00K | 5.42M | 235.00K | 48.00K | -52.00K | -5.00K | 130.00K | 36.00K | -194.00K | 175.00K |
| Operating Cash Flow | -4.41M | 3.82M | 1.65M | 66.00K | -1.56M | -1.26M | -2.15M | -4.09M | -3.95M | -3.37M |
| Capital Expenditures | -122.00K | -120.00K | -208.00K | — | — | — | — | — | 0 | 0 |
| Investing Cash Flow | -6.91M | -120.00K | -208.00K | 0 | 0 | 0 | 0 | 0 | 4.00K | -206.00K |
| Share Repurchases | — | — | — | — | — | — | — | — | 0 | 0 |
| Debt Issued | 6.25M | 0 | — | — | — | — | — | — | — | — |
| Debt Repaid | -985.00K | -1.00M | — | — | — | — | — | — | — | — |
| Financing Cash Flow | 12.12M | -3.74M | -1.41M | 0 | 2.14M | 946.00K | 1.00M | 0 | 0 | 0 |
| Net Change in Cash | 716.00K | -41.00K | 29.00K | 66.00K | 577.00K | -313.00K | -1.15M | -4.09M | -3.95M | -3.57M |
| Free Cash Flow | -4.53M | 3.70M | 1.44M | 66.00K | -1.56M | -1.26M | -2.15M | -4.09M | -3.95M | -3.37M |
This table shows 10 annual periods of Capstone's cash flow statement, from FY 2025 back to FY 2012, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CAPS's reporting calendar. What is a cash flow statement?